A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

NCT05779163 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumors

Interventions

DRUG: LBL-033 for Injection

Sponsor

Nanjing Leads Biolabs Co.,Ltd